Literature DB >> 33355697

Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy.

Antonio Esposito1,2, Anna Palmisano3,4, Marco Toselli5, Davide Vignale3,4, Alberto Cereda5, Paola Maria Vittoria Rancoita4,6, Riccardo Leone3,4, Valeria Nicoletti3,4, Chiara Gnasso3,4, Alberto Monello7, Andrea Biagi7, Piergiorgio Turchio7, Giovanni Landoni4,8, Guglielmo Gallone9, Giacomo Monti8, Gianni Casella10, Gianmarco Iannopollo10, Tommaso Nannini10, Gianluigi Patelli11, Luisa Di Mare11, Marco Loffi12, Pietro Sergio12, Davide Ippolito13, Sandro Sironi14, Gianluca Pontone15, Daniele Andreini15, Elisabetta Maria Mancini15, Clelia Di Serio4,6, Francesco De Cobelli3,4, Fabio Ciceri4,16, Alberto Zangrillo4,8, Antonio Colombo5, Carlo Tacchetti3,4, Francesco Giannini5.   

Abstract

OBJECTIVES: Enlarged main pulmonary artery diameter (MPAD) resulted to be associated with pulmonary hypertension and mortality in a non-COVID-19 setting. The aim was to investigate and validate the association between MPAD enlargement and overall survival in COVID-19 patients.
METHODS: This is a cohort study on 1469 consecutive COVID-19 patients submitted to chest CT within 72 h from admission in seven tertiary level hospitals in Northern Italy, between March 1 and April 20, 2020. Derivation cohort (n = 761) included patients from the first three participating hospitals; validation cohort (n = 633) included patients from the remaining hospitals. CT images were centrally analyzed in a core-lab blinded to clinical data. The prognostic value of MPAD on overall survival was evaluated at adjusted and multivariable Cox's regression analysis on the derivation cohort. The final multivariable model was tested on the validation cohort.
RESULTS: In the derivation cohort, the median age was 69 (IQR, 58-77) years and 537 (70.6%) were males. In the validation cohort, the median age was 69 (IQR, 59-77) years with 421 (66.5%) males. Enlarged MPAD (≥ 31 mm) was a predictor of mortality at adjusted (hazard ratio, HR [95%CI]: 1.741 [1.253-2.418], p < 0.001) and multivariable regression analysis (HR [95%CI]: 1.592 [1.154-2.196], p = 0.005), together with male gender, old age, high creatinine, low well-aerated lung volume, and high pneumonia extension (c-index [95%CI] = 0.826 [0.796-0.851]). Model discrimination was confirmed on the validation cohort (c-index [95%CI] = 0.789 [0.758-0.823]), also using CT measurements from a second reader (c-index [95%CI] = 0.790 [0.753;0.825]).
CONCLUSION: Enlarged MPAD (≥ 31 mm) at admitting chest CT is an independent predictor of mortality in COVID-19. KEY POINTS: • Enlargement of main pulmonary artery diameter at chest CT performed within 72 h from the admission was associated with a higher rate of in-hospital mortality in COVID-19 patients. • Enlargement of main pulmonary artery diameter (≥ 31 mm) was an independent predictor of death in COVID-19 patients at adjusted and multivariable regression analysis. • The combined evaluation of clinical findings, lung CT features, and main pulmonary artery diameter may be useful for risk stratification in COVID-19 patients.

Entities:  

Keywords:  COVID-19; Hypertension, pulmonary; Pulmonary artery; Thorax; Tomography, X-ray computed

Mesh:

Year:  2020        PMID: 33355697      PMCID: PMC7755582          DOI: 10.1007/s00330-020-07622-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  1 in total

1.  Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis.

Authors:  Fabio Ciceri; Luigi Beretta; Anna Mara Scandroglio; Sergio Colombo; Giovanni Landoni; Annalisa Ruggeri; Jacopo Peccatori; Armando D'Angelo; Francesco De Cobelli; Patrizia Rovere-Querini; Moreno Tresoldi; Lorenzo Dagna; Alberto Zangrillo
Journal:  Crit Care Resusc       Date:  2020-04-15       Impact factor: 2.159

  1 in total
  10 in total

1.  A Novel Non-Invasive Device for the Assessment of Central Venous Pressure in Hospital, Office and Home.

Authors:  Emanuela Marcelli; Laura Cercenelli; Barbara Bortolani; Saverio Marini; Luca Arfilli; Alessandro Capucci; Gianni Plicchi
Journal:  Med Devices (Auckl)       Date:  2021-05-13

2.  Clinical implications of microvascular CT scan signs in COVID-19 patients requiring invasive mechanical ventilation.

Authors:  Giorgia Dalpiaz; Lorenzo Gamberini; Aldo Carnevale; Savino Spadaro; Carlo Alberto Mazzoli; Sara Piciucchi; Davide Allegri; Chiara Capozzi; Ersenad Neziri; Maurizio Bartolucci; Francesco Muratore; Francesca Coppola; Antonio Poerio; Emanuela Giampalma; Luca Baldini; Tommaso Tonetti; Iacopo Cappellini; Davide Colombo; Gianluca Zani; Lorenzo Mellini; Vanni Agnoletti; Federica Damiani; Giovanni Gordini; Cristiana Laici; Giuliano Gola; Antonella Potalivo; Jonathan Montomoli; Vito Marco Ranieri; Emanuele Russo; Stefania Taddei; Carlo Alberto Volta; Gaetano Scaramuzzo
Journal:  Radiol Med       Date:  2022-01-16       Impact factor: 6.313

3.  Comparison of semiquantitative chest CT scoring systems to estimate severity in coronavirus disease 2019 (COVID-19) pneumonia.

Authors:  Akitoshi Inoue; Hiroaki Takahashi; Tatsuya Ibe; Hisashi Ishii; Yuhei Kurata; Yoshikazu Ishizuka; Yoichiro Hamamoto
Journal:  Eur Radiol       Date:  2022-01-12       Impact factor: 7.034

4.  Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD.

Authors:  Marc Miravitlles; Myriam Calle; Jesús Molina; Pere Almagro; José-Tomás Gómez; Juan Antonio Trigueros; Borja G Cosío; Ciro Casanova; José Luis López-Campos; Juan Antonio Riesco; Pere Simonet; David Rigau; Joan B Soriano; Julio Ancochea; Juan José Soler-Cataluña
Journal:  Arch Bronconeumol       Date:  2021-03-17       Impact factor: 6.333

5.  Mean Velocity of the Pulmonary Artery as a Clinically Relevant Prognostic Indicator in Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Blanca Trejo-Velasco; Ignacio Cruz-González; Manuel Barreiro-Pérez; Elena Díaz-Peláez; Pilar García-González; Ana Martín-García; Rocío Eiros; Soraya Merchán-Gómez; Candelas Pérez Del Villar; Oscar Fabregat-Andrés; Francisco Ridocci-Soriano; Pedro L Sánchez
Journal:  J Clin Med       Date:  2022-01-19       Impact factor: 4.241

Review 6.  Systematic review and meta-analysis on coronary calcifications in COVID-19.

Authors:  A Cereda; L Allievi; A Palmisano; G Tumminello; L Barbieri; A Mangieri; A Laricchia; A Khokhar; F Giannini; M Toselli; G M Sangiorgi; A Esposito; P Aseni; S Lucreziotti; A Mafrici; S Carugo
Journal:  Emerg Radiol       Date:  2022-04-30

Review 7.  Advanced cardiac imaging in the spectrum of COVID-19 related cardiovascular involvement.

Authors:  Anna Palmisano; Michele Gambardella; Tommaso D'Angelo; Davide Vignale; Raffaele Ascione; Marco Gatti; Giovanni Peretto; Francesco Federico; Amar Shah; Antonio Esposito
Journal:  Clin Imaging       Date:  2022-07-29       Impact factor: 2.420

8.  Pulmonary Artery Enlargement: An Independent Risk Factor for Mortality in Patients Hospitalized With COVID-19.

Authors:  Moussa A Riachy; Anis Ismail; Mohamad Awali; Fadi Farah; Sara F Haddad; Anthony Kerbage; Noel Aoun; Ghassan Sleilaty
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2022-07-21

Review 9.  Right ventricular dysfunction and pulmonary hypertension in COVID-19: a meta-analysis of prevalence and its association with clinical outcome.

Authors:  Yudi Her Oktaviono; Eka Prasetya Budi Mulia; Kevin Luke; David Nugraha; Irma Maghfirah; Agus Subagjo
Journal:  Arch Med Sci       Date:  2021-05-05       Impact factor: 3.707

10.  AI-SCoRE (artificial intelligence-SARS CoV2 risk evaluation): a fast, objective and fully automated platform to predict the outcome in COVID-19 patients.

Authors:  Carlo Tacchetti; Antonio Esposito; Anna Palmisano; Davide Vignale; Edda Boccia; Alessandro Nonis; Chiara Gnasso; Riccardo Leone; Marco Montagna; Valeria Nicoletti; Antonello Giuseppe Bianchi; Stefano Brusamolino; Andrea Dorizza; Marco Moraschini; Rahul Veettil; Alberto Cereda; Marco Toselli; Francesco Giannini; Marco Loffi; Gianluigi Patelli; Alberto Monello; Gianmarco Iannopollo; Davide Ippolito; Elisabetta Maria Mancini; Gianluca Pontone; Luigi Vignali; Elisa Scarnecchia; Mario Iannacone; Lucio Baffoni; Massimiliano Sperandio; Caterina Chiara de Carlini; Sandro Sironi; Claudio Rapezzi; Luca Antiga; Veronica Jagher; Clelia Di Serio; Cesare Furlanello
Journal:  Radiol Med       Date:  2022-08-29       Impact factor: 6.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.